Zydus Cadila gets USFDA approval to market generic version of Deferasirox tablets

Zydus Cadila, part of Cadila Healthcare group, on Tuesday said it has received final approval from the US health regulator to market its generic version of Deferasirox tablets used in treatment of chronic iron overload due to blood transfusions.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news